Medical News Today
Lenstec, Inc. -- a manufacturer of technologically-advanced implantable lenses -- today announced that the U.S. Food and Drug Administration has approved the company's Softec HD™ Intraocular Lens Implant (IOL) for treating patients with cataracts. The newly approved Softec HD is part of Lenstec's "Precision Series" of implantable IOLs that enable ophthalmologists to achieve previously unattainable predictability and precision in vision surgery.